Bosh sahifaATBPF • OTCMKTS
Antibe Therapeutics Ord Shs
0,22 $
18-okt, 7:30:00 (GMT-4) · USD · OTCMKTS · Ogohlantirish
AksiyalarAQSH qimmatli qogʻozi
Yopilish kursi
0,22 $
Yillik diapazon
0,11 $ - 0,89 $
Oʻrtacha hajm
27,54 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(CAD)dek, 2023Y/Y qiyosi
Daromad
Joriy xarajat
4,60 mln-1,42%
Sof foyda
-4,21 mln2,39%
Sof foyda marjasi
Har bir ulushga tushum
-0,08-32,96%
EBITDA
Amaldagi soliq stavkasi
Jami aktivlari
Jami passivlari
(CAD)dek, 2023Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
24,91 mln-41,20%
Jami aktivlari
56,36 mln-23,56%
Jami passivlari
30,42 mln-0,13%
Umumiy kapital
25,94 mln
Tarqatilgan aksiyalar
52,67 mln
Narxi/balansdagi bahosi
0,44
Aktivlardan daromad
-19,71%
Kapitaldan daromad
-41,30%
Naqd pulning sof oʻzgarishi
(CAD)dek, 2023Y/Y qiyosi
Sof foyda
-4,21 mln2,39%
Operatsiyalardan naqd pul
-3,84 mln-6,66%
Sarmoyadan naqd pul
11,04 mln1 975,38%
Moliyadan naqd pul
Naqd pulning sof oʻzgarishi
7,20 mln334,09%
Boʻsh pul
-2,47 mln-2 419,13%
Haqida
Antibe Therapeutics was a Toronto-based pharmaceutical company that develops pain and inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Founded in 2009, the company listed on the TSX Venture Exchange in 2013 and was moved to the Toronto Stock Exchange in November 2020. In 2015, Antibe acquired Citagenix, a distributor involved in regenerative medicine. On June 1, 2020, the company announced positive results in the final Phase 2 trial of its first drug Otenaproxesul. On March 29, 2021, the drug's Investigational New Drug application was cleared by the US Food and Drug Administration, allowing for human trials. In May 2024 the company went bankrupt and its stock was delisted from the Toronto Stock Exchange. Wikipedia
Tashkil etilgan
2009
Xodimlar soni
11
Yana
Bu sizni qiziqtirishi mumkin
Bu roʻyxat oxirgi qidiruvlar, kuzatilgan aksiyalar va boshqa faoliyatdan tuzilgan. Batafsil

Barcha axborotlar faqat maʼlumot sifatida “shundayligicha” taqdim etilgan, ulardan moliyaviy maslahat sifatida foydalanmang, ular savdo maqsadlari yoki investitsiya, soliq, yuridik, buxgalteriya yoki boshqa turdagi maslahat emas. Google investitsiya borasida maslahatchi emas, bu roʻyxatdagi kompaniyalar yoki ularning aksiyalari borasida hech qanday nuqtai nazar, tavsiya yoki fikr bildirmaydi. Har qanday savdoni boshlashdan oldin broker yoki moliyaviy vakil bilan maslahatlashib, narxlarni tekshiring. Batafsil
Aloqador qidiruvlar
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu